Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-21

Clinical Trial Update: Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors [Phase 1]

View source ↗

Summary

A Phase 1 pediatric trial evaluating acetylcysteine, mannitol, sodium thiosulfate, and a chemotherapy combination for malignant brain tumors was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acetylcysteine (Acetylcysteine)
  • Mannitol (mannitol)
  • Sodium thiosulfate (sodium thiosulfate)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Bone Marrow Suppression, Brain and Central Nervous System Tumors | Phase 1 | Status: TERMINATED